Journal of Controlled Release

The Journal of Controlled Release is a bimonthly peer-reviewed medical journal and the official journal of the Controlled Release Society. The journal contains papers detailing research involving the controlled release and delivery of drugs and other biologically active agents. Announcements and reports of future meetings pertaining to the activities of the Controlled Release Society are also included. The journal is abstracted and indexed in BIOSIS Previews, CAB Abstracts, Chemical Abstracts, Current Contents/Life Sciences, EMBASE, MEDLINE, Science Citation Index, and Scopus.

Publisher
Elsevier
History
1984-present
Impact factor
7.164 (2010)

Some content from Wikipedia, licensed under CC BY-SA

Medical research

Resveratrol, quercetin could provide new options for cancer therapy

Resveratrol and quercetin, two polyphenols that have been widely studied for their health properties, may soon become the basis of an important new advance in cancer treatment, primarily by improving the efficacy and potential ...

HIV & AIDS

An aspirin a day may keep HIV away, study finds

An affordable, globally available drug – low-dose Aspirin – shows promise as a new approach to preventing HIV transmission, a University of Manitoba study has found.

Parkinson's & Movement disorders

First photoactive drug to fight Parkinson's disease

An international team has designed the first potentially therapeutic photoactive drug, MRS7145, to fight Parkinson's disease, according to the new article in Journal of Controlled Release.

Oncology & Cancer

Cancer-killing proteins destroy tumor cells in bloodstream

Cornell researchers have discovered potent cancer-killing proteins that can travel by white blood cells to kill tumors in the bloodstream of mice with metastatic prostate cancer. The breakthrough study will be published Feb. ...

page 1 from 4